A curious-looking creature with a snaggletoothed grin, curly fur, and long ears has taken the UK by storm. Known as Labubu, this quirky character is part of the Monster series by Hong Kong-born artist Kasing Lung, produced by Chinese toy giant Pop Mart. Though around for over a decade, Labubu and its blind box counterparts have recently exploded in popularity, driven by viral TikTok trends and celebrity endorsements.
The blind box trend, familiar to fans of Japanese collectables like Sonny Angels or Smiskis, offers a simple but addictive premise: buy a sealed box without knowing which character you’ll get. Labubu has become the standout face of this phenomenon, sparking a collector frenzy across the UK.
What is Labubu?
Labubu is just one of many characters in Pop Mart’s Monster series. Inspired by Nordic folklore, it blends an “ugly-cute” aesthetic with a strong dose of mystery. Each Labubu comes in a series with a selection of styles, and always includes one rare “secret” design that is particularly hard to find. For example, in the Big Into Energy collection, the odds of unboxing the secret rainbow-toothed grey Labubu are 1 in 72.
The appeal? It’s a mix of nostalgia, rarity, and the thrill of the unknown. For many collectors in the UK, the experience mirrors childhood memories of lucky bags or trading Pokémon cards, but with a more stylish, adult edge. TikTok is flooded with over 1.3 million posts under the #labubu hashtag, with unboxing videos, trade swaps, and collection showcases forming a vibrant online community.
Celebrity and social media boost
Labubu’s popularity is no longer niche. Pop stars such as Dua Lipa, Lisa of BLACKPINK, and even Rihanna have been spotted with Labubu merchandise. Influencers and collectors across the UK, including former Love Island contestant Olivia Attwood, have also helped raise the profile of these odd little creatures.
Dublin-based collector Davie Jordan Andrews has built his own TikTok following through Labubu-related content, including unboxing videos and sourcing tips. “When I posted my video, I got over 100 messages asking where I got mine,” he said. “There’s a real community feel. People help each other find the figures they want—it’s wholesome.”
Why are they so popular in the UK?
The Labubu UK craze stems partly from scarcity. Pop Mart’s UK stores saw overwhelming demand for the toys, with reports of scuffles breaking out among customers. This led the company to temporarily pull Labubu stock from all 16 of its UK outlets, citing “potential safety issues.”
Pop Mart’s UK stores saw overwhelming demand for the toysiStock
Adding to their appeal is a strong element of “completionism.” Each series has a defined set of characters, and collectors are often determined to complete the entire run. This pursuit taps into the same psychological drivers that fuel gaming, achievement-hunting and stamp collecting. It also creates a highly active resale and trading market, with rare Labubus sometimes reselling for far above their retail price.
A growing global industry
Blind box toys are no longer a fringe interest. According to market analysts, the global value of blind box collectables is projected to hit $391.62 billion by 2030. Pop Mart, along with Japanese counterparts like Dreams Inc., is riding this wave with artist collaborations and limited-edition drops that keep collectors engaged and coming back for more.
Labubu’s rise in the UK is part of a broader trend where adult consumers seek out nostalgic joys in modern, design-driven formats. While traditional toys were once considered children’s domain, today’s blind box figures are marketed with sophistication, often viewed as art or lifestyle decor as much as playthings.
Concerns over waste and sustainability
With rising popularity, however, come concerns. Each blind box figure comes in multiple layers of packaging—foil, film, and cardboard—much of which may not be recycled. Pop Mart has said it uses recyclable cardboard and biodegradable CPP film for its bags, and it encourages customers to recycle. Still, critics argue that the environmental impact of mass-produced plastic figurines shouldn’t be overlooked.
As public pressure grows, toy companies may soon be pushed to invest more in eco-friendly materials and more sustainable practices.
Blind box collection
Whether seen dangling from a bag, showcased on a shelf, or being carefully unboxed on TikTok, Labubu’s unmistakable grin is hard to miss. What began as a niche collectable has evolved into a full-blown cultural moment in the UK, blending social connection, nostalgia, and artistry.
As blind box collecting continues to surge, Labubu’s popularity shows no sign of slowing down. From Tube commutes to social media feeds, the UK’s fascination with the furry little monster is now firmly embedded in everyday life—and with Pop Mart’s constant flow of new designs and series, the hunt is only just beginning.
A physician assistant (PA) internship isn't just another step in your education; it's a pivotal moment that can define your future in medicine. This is where you can seamlessly connect classroom theory with real-world practice, sharpen your clinical expertise, and develop your professional identity.
But to truly make the most of this experience, simply showing up isn't enough. Here's how to approach your internship with purpose and intention.
Set Clear Learning Goals Early
Before beginning your PA internship, think about what you hope to gain. Are you aiming to enhance your diagnostic reasoning? Is it to strengthen your communication with patients? Or perhaps become more comfortable with documentation? Defining these goals ahead of time allows you to focus your efforts.
It also helps to share these objectives with your supervisor right away. Don't assume they'll know what you need or want to learn. By aligning your personal goals with the internship's structure and your physician assistant program's curriculum, you can set the stage for a more focused and meaningful experience.
If you're looking to broaden your perspective, explore the PA internship offered by international programs or academic partners abroad. These experiences introduce you to new clinical environments, deepen your understanding of global healthcare challenges, and strengthen your cultural awareness.
Be Proactive, Not Passive
An internship is not the time to take a back seat. So, volunteer to present patients, assist with documentation, or observe procedures. Ask if you can participate in areas that support your learning goals, too.
Taking initiative signals that you're invested in your development. Whether it's offering to help with charting or expressing interest in a particular case, each step forward deepens your clinical experience and prepares you to work confidently alongside experienced healthcare professionals.
Learn From Every Team Member
Some of the most valuable lessons from your internship program won't come from physicians alone. Nurses, medical students, technicians, and administrative staff each bring unique perspectives that deepen your understanding of patient care and clinical operations.
Watch how nurses communicate with patients or how medical assistants manage fast-paced workflow. Building trust and professional rapport across the team strengthens your collaboration skills and prepares you for the teamwork essential in everyday clinical settings.
Ask Thoughtful Questions
You're expected to have questions, but it's how and when you ask them that makes the difference. Rather than asking basic facts you could look up later, focus on questions that demonstrate critical thinking and genuine engagement with patient care.
For instance, you can ask about clinical reasoning: "What factors led you to choose this treatment approach?" or "How did the patient's history influence your differential diagnosis?" These questions show you're thinking like a clinician, not just memorizing protocols. Understanding the "why" behind medical decisions will accelerate your development of clinical judgment.
Also, master the art of timing. If the clinical environment is hectic, make a quick note of your questions and ask them during a quieter moment. This approach shows respect for the workflow while ensuring you get the learning you need.
Master the Art of Charting
Effective documentation is an essential skill. It supports continuity of care, contributes to billing accuracy, and reflects your clinical understanding.
So, practice writing clear and structured notes. Focus on being concise while still capturing the full picture. Strong documentation skills will serve you well no matter where you practice in the medical field, whether in primary care, surgery, or a specialty clinic.
Embrace Feedback
Feedback from experienced medical professionals offers insights that textbooks and lectures simply can't. They have seen countless cases and can spot patterns, mistakes, and opportunities for improvement that you might miss. But remember, their critiques aren't personal attacks—they're investments in your development as a healthcare provider.
That said, learn to accept constructive feedback with maturity and openness. Listen actively without becoming defensive, ask clarifying questions when needed, and thank the person for their time and insight. Most importantly, act on what you learn. Adjust your approach, practice the suggested techniques, and follow up to show you've incorporated their guidance. This responsiveness demonstrates maturity and signals that you're serious about your professional growth, qualities that will serve you well beyond your internship.
Reflect Daily and Track Your Progress
A brief daily reflection can significantly enhance your learning. So, at the end of each day, take a few minutes to process what happened. Which cases challenged you most? When did you feel most confident in your decisions?
Whether you write in a journal or record short audio notes, making time to reflect and understand your experiences helps solidify what you've learned and build confidence in your clinical decision-making.
Balance Confidence With Humility
Confidence is important, but so is recognizing your limits. If you're unsure about something, speak up. Asking for guidance shows good judgment and a commitment to safe, effective care.
The key is to find the right balance. Know when to take initiative and when to pause and consult. This balance goes a long way in developing trust with both your team and the patients you serve.
Build Relationships That Last
An internship is a time to learn, but it's equally an opportunity to connect with people who can help shape your career. Supervisors and fellow interns you work alongside today may become your future colleagues, mentors, or professional references.
That said, maintain a respectful presence and express gratitude. Show interest in others' experiences, contribute meaningfully to team discussions, and demonstrate reliability in your responsibilities, too. People remember those who made their work easier and more enjoyable.
After your rotation ends, consider sending a thank-you note or staying in touch on professional platforms. These relationships can be invaluable as you move forward in your medical career and build your professional reputation.
Final Thoughts
A physician assistant internship is more than a box to check—it's your introduction to life as a healthcare provider. Treat it as an opportunity to grow, explore, and define your role within the broader medical field.
Stay focused, ask questions, take initiative, and reflect regularly. With a professional mindset and a commitment to learning, you'll transition smoothly from student to practicing PA and start making a real impact in your chosen healthcare setting.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Health officials expect the rollout to benefit around 220,000 adults over the next 3 years
NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
The programme aims to support 220,000 people over three years
Eligible patients must have a BMI over 40 and at least four obesity-related health issues
GP leaders raise concerns over increased workload
Pharmacists urge a broader weight management approach
NHS expands obesity treatment with Mounjaro
The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.
Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.
GPs express concern over added burden
While the rollout has been welcomed as a major step in tackling severe obesity, some family doctors have expressed concern over the operational challenges it may bring. The British Medical Association and other GP leaders have highlighted the need for additional training, resources and time to manage the expected rise in patient demand.
They warn that without extra support, the move could add further pressure to already stretched primary care services.
Calls for a comprehensive approach
Pharmacy experts and health professionals have stressed that Mounjaro should not be viewed as a standalone solution. Instead, they argue that it must be integrated into a broader weight management strategy that includes dietary changes, physical activity, and behavioural support.
There are also concerns about potential pressure on drug supplies as demand increases. Experts suggest that clear guidance on prescription protocols and supply management will be crucial to avoid shortages.
A targeted step in tackling obesity
The introduction of Mounjaro is part of the NHS’s wider effort to address rising obesity levels in the UK, which are closely linked to long-term health complications and increased strain on the health system. By targeting the most at-risk individuals, health officials hope the new measure will reduce future hospitalisations and improve overall health outcomes.
Keep ReadingShow less
Around 85% of the projected deaths are likely to involve people over the age of 65
Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.
Climate change driving deadly temperatures
Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.
The scientists estimate that human activity has increased the temperatures experienced during this heatwave by 2°C to 4°C, pushing the mercury beyond safe levels for many, particularly the elderly and those with underlying health conditions.
Dr Garyfallos Konstantinoudis from Imperial College London, who helped conduct the analysis, said: “Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. This real-time analysis reveals the hidden toll of heatwaves, and we want it to help raise the alarm.”
Deaths concentrated among older adults
The analysis, based on decades of UK temperature and mortality data across more than 34,000 locations in England and Wales, projects around 570 excess deaths between Thursday and Sunday. Of these, approximately 129 are expected in London. Scientists believe the figure may be underestimated, as early summer heatwaves often catch people unprepared.
Around 85% of the projected deaths are likely to involve people over the age of 65, who are particularly vulnerable to heat stress. Other at-risk groups include infants, pregnant individuals, and people with cardiovascular or respiratory conditions.
Dr Malcolm Mistry from the London School of Hygiene & Tropical Medicine (LSHTM), who contributed to the study, warned: “Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people, and those with pre-existing health conditions.”
Health and emergency services under pressure
The UK Health Security Agency (UKHSA) issued an amber heat-health alert on Thursday, which is set to remain in effect until 9 am on Monday. The warning highlights a risk of increased deaths and severe impacts on health and social care systems.
Medical professionals have reported a rise in heat-related illnesses. Dr Lorna Powell, an urgent care doctor in East London, said: “We are seeing cases of heat exhaustion rising. It can quickly trigger more serious illnesses, as dehydration sets in and the cardiovascular system becomes overwhelmed.”
The UKHSA advises people to stay out of the sun between 11 am and 3 pm, drink plenty of fluids, keep indoor spaces cool, and check in on vulnerable neighbours and family members. Data from a recent study indicates that approximately 80% of UK homes overheat during summer, further exacerbating health risks for residents.
Urban areas face greater risk
City dwellers, especially those in poorly ventilated flats, face higher health risks during heatwaves. Heat becomes trapped in buildings, leading to prolonged exposure, especially at night when outdoor temperatures remain high.
Professor Antonio Gasparrini of LSHTM, another contributor to the analysis, said: “When temperatures push past the limits populations are acclimatised to, excess deaths can increase very rapidly. Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.”
Poor preparedness criticised
Between 2020 and 2024, more than 10,000 people died in the UK due to heatwaves, according to UKHSA data. Yet in April 2025, the government’s climate advisers criticised the UK’s readiness to deal with extreme heat, calling preparations “inadequate, piecemeal and disjointed”.
Despite growing awareness of climate-related risks, systemic changes to improve resilience, such as retrofitting homes and bolstering healthcare capacity, have been limited.
Government removes barriers to home EV chargers
As part of broader environmental measures, the UK government recently eliminated the requirement for planning permission to install electric vehicle (EV) chargers at homes and businesses. This change is estimated to save an average of £1,100 per installation, according to the Department for Transport, and may aid the shift to low-carbon transport. While unrelated to heatwave policy, the move reflects the government’s push for green infrastructure.
Air quality worsens amid heat
Alongside the heat, a spike in air pollution has raised additional concerns. London has been issued a high ozone pollution alert, with people suffering from respiratory conditions such as asthma advised to avoid outdoor exercise.
Heatwaves becoming more frequent and intense
Global data shows that extreme heat causes more deaths than floods, hurricanes, or earthquakes. According to insurer Swiss Re, heatwaves are responsible for about 500,000 deaths globally each year. “Extreme heat events are more dangerous than natural catastrophes in terms of human lives lost, yet the true cost is only starting to come to light,” said Nina Arquint, chief executive of corporate solutions at Swiss Re.
In 2024, the planet recorded its hottest year on record, driven by climate change and rising emissions. Carbon dioxide levels from fossil fuels continue to increase, pushing the world closer to dangerous temperature thresholds.
A recent report by the UK Climate Change Committee estimates that if global temperatures rise by 2°C above pre-industrial levels, annual heat-related deaths in the UK could exceed 10,000 by 2050.
The scientists behind the current analysis hope that quantifying the hidden human cost of heatwaves will prompt more urgent action to reduce emissions and prepare the UK for a hotter future.
Keep ReadingShow less
In a world still catching up with the truths of trans identity
AS Pride Month sweeps across the world in a blaze of colour, protest and celebration, one Indian voice continues to rise with unwavering authenticity. Ella D’Verma is reshaping narratives as a transgender model, fearless LGBTQ+ advocate and digital content creator with a powerful global following.
In a world still catching up with the truths of trans identity, her visibility has become vital – the embodiment of pride in action. In this exclusive conversation with Eastern Eye, she speaks about her journey, the importance of visibility, self-expression, navigating the fashion industry as a trans model, representation, and her vision for the future.
Pride is about honouring those who came before us and ensuring our stories are not lostInstagram / elladverma
What does Pride Month mean to you?
Given the struggles and hardships the LGBTQ+ community has faced, it is only fair that we take this time to honour our stories. For me, the best part of Pride is the conversations and representation it brings. Even if
it is sometimes reduced to marketing or tokenism, the community is being acknowledged. That visibility helps those who may not have the courage to come out yet feel represented. Pride is about honouring those who came before us and ensuring our stories are not lost.
How did lockdown influence your decision to embrace your identity and share it publicly?
Those were difficult times for everyone, but I was fortunate to have my family around and healthy. Lockdown made me realise the fragility of life. It helped me understand that I no longer wanted to live a lie. Being at home kept me away from school, relatives and opinions – that gave me the space to start expressing myself on social media.
Lockdown made me realise the fragility of lifeInstagram / elladverma
Was there a pivotal moment when you realised the importance of being visible and authentic?
The arts were my escape. Whenever I got on stage, I told myself I was good at what I did, even if I was being bullied or felt uncomfortable at home. But one day, the discomfort with myself became overwhelming – I got on stage and forgot my lines. That had never happened to me before. In that moment, it hit me that hiding my identity was costing me too much. That was the moment I came out to my mum.
What challenges have you faced in the fashion industry as a trans model?
Honestly, a lot of garments are not designed for the average cisgender woman, let alone a transgender woman. With my body type, it is often difficult to find clothes that fit well or make me feel comfortable. It has been a journey of accepting that my body is different and not everyone caters to it. I have had to embrace that as part of my story.
How have you learnt to navigate that space?
It is about trusting yourself, knowing your body and what suits it. I have learnt to speak up when something is not working, whether it is makeup or styling. I know what enhances my features, and that confidence makes a shoot successful. Over time, I have stopped mincing words on set. Feeling confident in how I look is 90 per cent of the job.
How do you feel about being recognised as a model who is transgender versus being labelled a transgender model?
My identity is not something I hide or feel ashamed of – I take pride in it. But I am also aware that it is sacred. I do not feel the need to bring it up unless it is relevant. If a job or campaign centres on that identity, I am happy to speak about it. But when my gender is unnecessarily
highlighted, I draw the line. I am a model who happens to be transgender, not a “transgender model”. Orientation should never come before occupation.
You cannot make meaningful change without representation in mainstream mediaInstagram / elladverma
What can the fashion and content industries do to better support transgender individuals?
Ideally, we need new rules and inclusive product design. But realistically, the most important first step is representation. You cannot make meaningful change without representation in mainstream media. That is how you create space, shift narratives, and make inclusion more than a trend.
How do you take care of your mental well-being in the face of challenges like rejection?
It is an ongoing process – none of us is immune to the pain of rejection. But it is about reminding yourself that your worth does not lie in booking a show, securing a deal, or finding a partner. You are whole in yourself, not in your achievements.
How do you hope transgender representation evolves in the future?
Representation is improving, but often it is still tied to a sense of shock, as if having a trans character is automatically a plot point. What I would love to see is
trans stories being told as simply human stories, not with a “transgender” label attached. The long-term goal is for trans identities to be treated as standard, not sensationalised.
Instagram: @elladverma
Keep ReadingShow less
'The Lancet' and presentations at the American Diabetes Association’s 2025
A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.
Record weight loss from Amycretin injections
Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.
Amycretin, developed by Novo Nordisk, the same pharmaceutical company behind Wegovy and the Type 2 diabetes treatment Ozempic, works by targeting both the GLP-1 and amylin receptors. These receptors help control blood sugar levels and suppress appetite.
Strong results for oral version
In addition to the injectable form, a parallel study explored amycretin in tablet form. Conducted over 12 weeks and involving 144 adults, the trial showed those on the highest daily dose (100mg) lost 13.1 per cent of their body weight – a substantial result for an oral medication over such a short period.
Both studies also reported improvements in metabolic and glycaemic health. The authors wrote that amycretin “effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity”. They called for longer and larger trials to assess long-term safety and optimise the dosing regimen.
Pills could overtake jabs in the future
While the injectable version delivered record weight loss, the promising results from the pill suggest oral treatments could soon rival or even surpass jabs in convenience and effectiveness.
Health experts have described the development of an effective pill as a potential “game-changer” in tackling obesity. Professor Jason Halford, former president of the European Association for the Study of Obesity, said: “They will be easier to produce, store and use, and this should mean they could become more widely available. That would produce a significant impact on the nation’s health.”
Limited NHS rollout as private demand surges
Obesity remains a major issue in the UK, with around two in three adults considered overweight or obese. The NHS is set to begin prescribing GLP-1 injections from late June 2025, although the initial rollout will be limited. Around 220,000 people are expected to be treated through the NHS within the next three years.
Eligibility criteria are strict, covering only the most obese patients with at least four chronic health conditions linked to excess weight. Meanwhile, private use of these medications has surged, with an estimated 1.5 million people in the UK having already purchased jabs like Wegovy.
Wegovy also shows promise at higher doses
Separately, another study presented at the ADA meeting focused on Wegovy (semaglutide), examining the effects of a higher weekly dose of 7.2mg. This led to average weight loss of 20.7 per cent over 72 weeks, up from 13.7 per cent at the standard dose used in earlier trials.
As competition intensifies in the weight-loss drug market, amycretin’s early results, particularly in tablet form, suggest it could play a major role in the future of obesity treatment.
Amitabh Bachchan reveals why he praises Abhishek publicly but not Jaya or Aishwarya